logo

EVIDENCE • EXPERIENCE • OUTCOMES

INTELLIGENCE BYMDReviewer
Home
About
Peptides
Contact
Back
Pre-approval drug. This compound is in active clinical trials and is not yet FDA-approved. Information here is for situational awareness only and should not be used to inform prescribing decisions.
  • No Preview Available

Anamorelin Hydrochloride

PipelinePhase 2PeptideInvestigationalNot approved yet. Being tested in human clinical trials.
Generic:
anamorelin
Sponsors:
M.D. Anderson Cancer Center, National Cancer Institute (NCI)
Active US trials:
2
Earliest primary completion:
Dec 27, 2019
👋

No perspectives yet — be the first!

100% anonymous · Verified U.S. prescribers only

(no name, NPI, or practice ever shown)

On this page

  • Synopsis

Trials

  • Clinical trials
  • About this drug

Physicians

  • Physician Buzz
Similar Products
medicine
Megestrol Acetate
medicine
Megace ES
medicine
Dronabinol
medicine
Valproic Acid
Synopsis
Generated with AlphaAI
Product:
Anamorelin Hydrochloride
Category:
Indication:
Mechanism:
Safety:
Dosing:
Patient:
Reviews:
No reviews yet
see more
Disclaimer: The synopsis and product information provided on Alpha.MD are derived from openFDA data and are for informational purposes only. This information may not be comprehensive, accurate, or up-to-date. Clinicians should exercise their own professional judgment in interpreting and using this information, and consult the official prescribing information for the most accurate and current details.

Clinical trials (2)

NCTPhaseStatusSponsorPrimary Completion
NCT03035409Phase 2ACTIVE_NOT_RECRUITINGM.D. Anderson Cancer CenterDec 27, 2019
NCT03637816Phase 2ACTIVE_NOT_RECRUITINGM.D. Anderson Cancer CenterDec 31, 2026
Status: Investigational
Tested in peopleEvidence: Tested in peopleTested in at least one proper controlled study in people, with results.

About this drug

Status
Active in clinical trials
Last Refreshed
Nov 13, 2026

Physician Buzz

Pre-Approval Insights

Be the First to Share Your Perspective

Share your pre-launch perspective on Anamorelin Hydrochloride and help peers make informed prescribing decisions.

Your 45-second perspective helps thousands of colleagues.

Help Peers Make Better Decisions

Your real-world insights guide colleagues

Anonymous to Pharmaceutical Companies

Your identity stays private — only specialty/region shown

See Peer Benchmarks

Compare your perspective to specialty peers

There isn't any reviews posted yet. You can be the first to review the product